Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Am J Prev Med. 2016 Jul;51(1 Suppl 1):S39–S47. doi: 10.1016/j.amepre.2016.02.019

Table 3.

Themes from Key Informant Interviews with Newborn Screening Stakeholders, by Public Health Domain (n=13 States)

Public health domain Selected activities among high scoring states Related challenges or issues
Data collection and analysis
  • Disseminated questionnaires to individual providers or contracted treatment centers on quarterly or annual basis to ensure children were in care.

  • Used secondary data (e.g., hospital data, Medicaid claims) for comprehensive needs assessments and activity planning.

  • Limited capacity to analyze data from providers or secondary sources.

  • Most data collection/analysis activities are not truly population level given population mobility, loss to follow-up.

Policy development
  • Convened newborn screening advisory. committees/hemoglobinopathies working groups.

  • Created state plans/consortia with key stakeholders.

  • Used a regular planning cycle that coincided with grant funding for treatment centers to assess needs and inform programs.

  • Collaborated with state Medicaid or children with special health care needs programs.

  • Held annual family day at state capitol to increase awareness of sickle cell disease among policy makers.

  • Demographic changes in states with increasing Hispanic and African populations.

  • Lack of funding to for planning or fully implementing plans and programs.

  • Reliance on dedicated individuals (advocates, specialists) who drive policy and programming and are difficult to replace.

Quality assurance
  • Developed standards of care (e.g., care pathways for emergency department visits, pain management, medical home) in consultation with stakeholders at state and/or regional level.

  • Leveraged contracts (funded or unfunded) with designated treatment centers to set standards, and to monitor and evaluate activities.

  • Conducted annual newborn screening program evaluations that included parent satisfaction surveys.

  • Utilized newborn screening program funded hemoglobin follow-up coordinator at treatment centers to track and reduce time to specialist referral.

  • Reported to state legislature on meeting goals for penicillin prophylaxis.

  • Reliance on treatment centers/specialists to develop standards of care; perception of limited role for newborn screening program

  • Most quality improvement activities conducted at individual treatment centers; not statewide and not coordinated with or led by newborn screening program.

Coordination
  • Held annual conferences that included professional organizations, churches, community based organizations, etc.

  • Convened contracted treatment centers annually to increase coordination and communication.

  • Created memoranda of understanding or other agreements with community based organizations so they could send them information on positive screens/trait, and they could do outreach.

  • Automatically referred affected children to children with special health care needs case management, Early Intervention; collaborated with school nurses.

  • Difficulty engaging primary care physicians across the state; many individuals each with very few affected patients.

  • Collaborations with community based organizations vary greatly depending on their size, number, history of leadership and involvement with newborn screening program and other organizations.

  • Lack of mechanisms to encourage coordination and communication across treatment centers.

Workforce development
  • Provided updated information on sickle cell disease for clinicians and families in print and online.

  • Held annual symposia or meetings to provide education to a range of providers and consumers.

  • Created a written education plan for clinicians; comprehensive treatment handbook.

  • Funded local newborn screening projects to provide outreach and education to providers (example: survey of school nurses to inform education efforts).

  • Trained counselors at community based organizations to provide trait counseling to families.

  • Need for increased knowledge among care providers in emergency departments, urgent care centers in treating sickle cell crises.

  • Lack of providers for adolescents transitioning out of pediatric specialty care.

Access to services
  • Increased access to care through mobile clinics in rural areas or collaborations with community health centers.

  • Used regional social workers or newborn screening program-funded coordinators at treatment centers to ensure follow-up.

  • Developed computer systems that allow newborn screening program and treatment centers to share information about screening results, treatment plans, etc.

  • Conducted focus groups with parents to evaluate access to care.

  • Tracked receipt of services (when number of treatment centers is small).

  • Most states track children only until confirmatory diagnosis or initiation of specialty care.

  • Size/structure of state and location/number of treatment centers may have a significant impact on follow-up and tracking activities.

  • Few states reported transition services for adolescents moving on to adult care.